News
Public · Published
CAPILLARY: Q2 consolidated profit reached ₹219.16 million; H1 absorbed a ₹333.86 million fraud loss
Capillary Technologies reported Q2 FY27 consolidated revenue of ₹2,713.55 million and net profit of ₹219.16 million. For the first half of FY27, net profit was ₹123.64 million, including a ₹333.86 million exceptional fraud loss in Q1; insurance recovery is pending.
Published:
Updated:
What happened
Capillary Technologies reported Q2 FY27 consolidated revenue of ₹2,713.55 million and net profit of ₹219.16 million. For the first half of FY27, net profit was ₹123.64 million, including a ₹333.86 million exceptional fraud loss in Q1; insurance recovery is pending.
Confirmed
Global impact / market context
The Q1 fraud loss reduced first-half profit despite a profitable second quarter. If insurance recovery is received, it could offset some of that loss and increase cash available; until then, the timing and amount of any recovery remain uncertain.
Analyst inference
The figures show a contrast between second-quarter earnings and lower first-half profit after the fraud loss. Investors assessing the company’s performance may distinguish recurring business results from the exceptional charge, while treating pending insurance recovery as an unresolved factor.
Analyst inference
What to watch
- Watch for any update on the pending insurance recovery, including whether Capillary reports a payment and how much of the ₹333.86 million fraud loss it offsets. Analyst inference
- Compare future quarterly revenue and profit with Q2 FY27’s reported figures to see whether earnings continue after the one-time Q1 fraud loss. Analyst inference
- Look for further details on the Q1 fraud loss, such as its cause or any effect on operations, since the supplied article gives no additional explanation. Analyst inference
Evidence
- Original source link unavailable